- Home
- FUSB vs YI Comparison
FUSB vs YI Comparison
Compare FUSB & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- YI
- Stock Information
- Founded
- FUSB 1952
- YI 2010
- Country
- FUSB United States
- YI China
- Employees
- FUSB N/A
- YI N/A
- Industry
- FUSB Major Banks
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- FUSB Finance
- YI Consumer Staples
- Exchange
- FUSB Nasdaq
- YI Nasdaq
- Market Cap
- FUSB 72.6M
- YI 70.0M
- IPO Year
- FUSB N/A
- YI N/A
- Fundamental
- Price
- FUSB $12.85
- YI $8.00
- Analyst Decision
- FUSB
- YI
- Analyst Count
- FUSB 0
- YI 0
- Target Price
- FUSB N/A
- YI N/A
- AVG Volume (30 Days)
- FUSB 2.3K
- YI 11.5K
- Earning Date
- FUSB 07-23-2025
- YI 06-19-2025
- Dividend Yield
- FUSB 2.20%
- YI N/A
- EPS Growth
- FUSB N/A
- YI N/A
- EPS
- FUSB 1.28
- YI N/A
- Revenue
- FUSB $38,449,000.00
- YI $1,984,717,013.00
- Revenue This Year
- FUSB N/A
- YI N/A
- Revenue Next Year
- FUSB N/A
- YI N/A
- P/E Ratio
- FUSB $9.95
- YI N/A
- Revenue Growth
- FUSB N/A
- YI N/A
- 52 Week Low
- FUSB $8.75
- YI $4.15
- 52 Week High
- FUSB $14.30
- YI $12.90
- Technical
- Relative Strength Index (RSI)
- FUSB 65.47
- YI 49.11
- Support Level
- FUSB $12.46
- YI $7.40
- Resistance Level
- FUSB $12.75
- YI $8.69
- Average True Range (ATR)
- FUSB 0.10
- YI 0.41
- MACD
- FUSB 0.05
- YI -0.02
- Stochastic Oscillator
- FUSB 100.00
- YI 46.51
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.